Ranked #3,756 of 8,699 institutional investors
Davern Capital Partners, LP
Ny, NY
$474M
US stock portfolio at live prices · today +$957K (+0.20%)
Live prices, last trade 10:18 AM ET
- Value at quarter end (Q3 2026)
- $514M
- Change from Q2 2026
- −$72.5M (−12.36%)
- Positions
- 15 · 5 new, 3 sold out
- Filed
- Nov 12, 2026
Not counted in the ranking: none$111M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesINSM 15.3%BNTX 11.9%REGN 8.05%ARGX 7.45%IONS 6.37%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| INSM Insmed Incorporated | 496,047 | $72.4M | 15.3% | Reduced −11% |
| BNTX BioNTech SE | 682,148 | $56.3M | 11.9% | Reduced −10% |
| REGN Regeneron Pharmaceuticals, Inc. | 40,661 | $38.2M | 8.05% | Reduced −56% |
| ARGX argenx SE | 37,597 | $35.3M | 7.45% | New |
| IONS Ionis Pharmaceuticals, Inc. | 1,087,142 | $30.2M | 6.37% | Added +36% |
| NTRA Natera, Inc. | 63,200 | $17.7M | 3.72% | Reduced −47% |
| VRDN Viridian Therapeutics, Inc. | 560,710 | $17.5M | 3.69% | New |
| LLY Eli Lilly and Company | 12,600 | $17.3M | 3.64% | New |
| VERA Vera Therapeutics, Inc. | 628,274 | $16.7M | 3.52% | Added +26% |
| ABVX ABIVAX Société Anonyme | 219,183 | $16.0M | 3.37% | New |
| LEGN Legend Biotech Corporation | 828,880 | $13.2M | 2.79% | Reduced −30% |
| MLYS Mineralys Therapeutics, Inc. | 695,152 | $10.2M | 2.16% | Reduced −19% |
| ARWR Arrowhead Pharmaceuticals, Inc. | 229,300 | $9.9M | 2.09% | New |
| GENB Generate Biomedicines, Inc. | 824,679 | $8.7M | 1.83% | Unchanged |
| AVTX Avalo Therapeutics, Inc. | 564,441 | $4.0M | 0.83% | Added +20% |